We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Steroid-Like Hormone Prompts Change of Morphology in Parasitic Nematodes

By LabMedica International staff writers
Posted on 09 Jun 2009
Researchers have identified a chemical compound that causes parasitic nematode worms to morph prematurely into the stage requiring feeding from host tissue, which results in the worms starving to death before they can establish an infection.

According to the World Health Organization (Geneva, Switzerland), parasitic nematodes infect about two billion people worldwide and severely sicken some 300 million, at least 50% being school-age children.

Investigators from the University of Texas Southwestern Medical Center (Dallas, USA) worked with the free-living worm Caenorhabditis elegans as well as with the parasitic nematode Strongyloides stercoralis. More...
Following up on previous studies showing that the steroid-like hormone dafachronic acid prompted worm larvae to mature from the stage in which they infect a host to the stage in which they start feeding on the host, the investigators sought to establish the molecular mechanism basis for this effect.

The researchers reported in the June 2, 2009, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) that they used X-ray crystallography to solve the three-dimensional structure of the S. stercoralis nuclear receptor DAF-12 ligand-binding domain cocrystallized with dafachronic acids. This data revealed the molecular basis for DAF-12 ligand binding and identified nuclear receptors as unique therapeutic targets in parasitic nematodes.

The next step is to screen large libraries of chemicals to search for compounds that behave like dafachronic acid and that could possibly be developed into pesticides that could be spread in high-infection areas.

"What keeps these parasites infectious is the lack of production of dafachronic acid,” said senior author Dr. David Mangelsdorf, professor of pharmacology at the University of Texas Southwestern Medical Center. "Once they get inside the host, however, something switches them on to begin making this compound. We can interrupt the worm's life cycle just by giving it this compound when it is in the infectious state, before it enters a host.”

Related Links:
World Health Organization
University of Texas Southwestern Medical Center



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.